{
    "name": "trifarotene",
    "comment": "Rx",
    "other_names": [
        "Aklief"
    ],
    "classes": [
        "Acne Agents",
        "Topical",
        "Retinoid-like Agents",
        "Topical"
    ],
    "source": "https://reference.medscape.com/drug/aklief-trifarotene-4000014",
    "pregnancy": {
        "common": [
            "Available data from clinical trials with use in pregnant women have not identified a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes",
            "There are case reports of major birth defects similar to those seen in fetuses exposed to oral retinoids in pregnant women exposed to other topical retinoids, but these reports do not establish a pattern or association with retinoid-related embryopathy",
            "There are no data on the presence of trifarotene in human milk, the effects on the breastfed infant, or the effects on milk production",
            "Trifarotene was present in rat milk with oral administration of the drug",
            "When present in animal milk, it is likely that the drug will be present in human milk; topical administration of large amounts of trifarotene may result in sufficient systemic absorption to produce detectable quantities in human milk ",
            "Consider the developmental and health benefits of breastfeeding, along with the mother’s clinical need and any potential adverse effects on the breastfed infant from the drug or from the underlying maternal condition"
        ],
        "specific": [
            {
                "type": "Animal data",
                "description": [
                    "In animal reproduction studies, oral doses of trifarotene administered to pregnant rats and rabbits during organogenesis that resulted in systemic exposures more than 800 times the systemic exposure at the maximum recommended human dose (MRHD) of topical cream resulted in adverse fetal effects, including fetal deaths and external, visceral, and skeletal malformations"
                ]
            },
            {
                "type": "Clinical considerations",
                "description": [
                    "To minimize potential exposure to the breastfed infant via breastmilk, use on the smallest area of skin and for the shortest duration possible while breastfeeding",
                    "Advise breastfeeding women not to apply directly to the nipple and areola to avoid direct infant exposure"
                ]
            }
        ]
    },
    "lactation": {
        "common": [
            "There are no data on the presence of trifarotene in human milk, the effects on the breastfed infant, or the effects on milk production",
            "Trifarotene was present in rat milk with oral administration of the drug",
            "When present in animal milk, it is likely that the drug will be present in human milk; topical administration of large amounts of trifarotene may result in sufficient systemic absorption to produce detectable quantities in human milk ",
            "Consider the developmental and health benefits of breastfeeding, along with the mother’s clinical need and any potential adverse effects on the breastfed infant from the drug or from the underlying maternal condition"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "None"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "Minimize unprotected exposure to ultraviolet rays (including sunlight and sunlamps) during treatment; exercise caution in patients who normally experience high levels of sun exposure and those with inherent sensitivity to sun; use sunscreen products and protective clothing over treated areas when exposure cannot be avoided"
            ],
            "specific": [
                {
                    "type": "Skin irritation",
                    "description": [
                        "May experience erythema, scaling, dryness, and stinging/burning",
                        "Maximum severity of these reactions typically occurred within the first 4 weeks of treatment, and severity decreased with continued use of the medication",
                        "Advise to use a moisturizer, reduce the frequency of application, or suspend use temporarily",
                        "If severe reactions persist, consider discontinuing treatment "
                    ]
                }
            ]
        }
    },
    "interactions": [],
    "adverse effects": [
        {
            "name": "Mild dryness",
            "percent": "39"
        },
        {
            "name": "face",
            "percent": "37.5"
        },
        {
            "name": "Mild scaling",
            "percent": "36.5"
        },
        {
            "name": "face",
            "percent": "32.9"
        },
        {
            "name": "Mild stinging",
            "percent": "30.6"
        },
        {
            "name": "burning",
            "percent": "29.7"
        },
        {
            "name": "face",
            "percent": "29.7"
        },
        {
            "name": "Mild dryness",
            "percent": "28.4"
        },
        {
            "name": "trunk",
            "percent": "27.1"
        },
        {
            "name": "Mild erythema",
            "percent": "26.5"
        },
        {
            "name": "face",
            "percent": "26.1"
        },
        {
            "name": "Moderate dryness",
            "percent": "16.1"
        },
        {
            "name": "face",
            "percent": "18.7"
        },
        {
            "name": "Mild scaling",
            "percent": "13.7"
        },
        {
            "name": "trunk",
            "percent": "20.6"
        },
        {
            "name": "Moderate erythema",
            "percent": "10.9"
        },
        {
            "name": "face",
            "percent": "4.2-7.5"
        },
        {
            "name": "Moderate scaling",
            "percent": "6.2"
        },
        {
            "name": "face",
            "percent": "5.9"
        },
        {
            "name": "Mild erythema",
            "percent": "2.6-5.5"
        },
        {
            "name": "trunk",
            "percent": "5.2"
        },
        {
            "name": "Mild stinging",
            "percent": "4.9"
        },
        {
            "name": "burning",
            "percent": "4.8"
        },
        {
            "name": "trunk",
            "percent": "4.3"
        },
        {
            "name": "Moderate dryness",
            "percent": "2.4-4.6"
        },
        {
            "name": "trunk",
            "percent": "1.8"
        },
        {
            "name": "Moderate erythema",
            "percent": "1.7"
        },
        {
            "name": "trunk",
            "percent": null
        },
        {
            "name": "Moderate scaling",
            "percent": null
        },
        {
            "name": "trunk",
            "percent": null
        },
        {
            "name": "Moderate stinging",
            "percent": null
        },
        {
            "name": "burning",
            "percent": null
        },
        {
            "name": "face",
            "percent": null
        },
        {
            "name": "Moderate stinging",
            "percent": null
        },
        {
            "name": "burning",
            "percent": null
        },
        {
            "name": "trunk",
            "percent": null
        },
        {
            "name": "Application site irritation",
            "percent": null
        },
        {
            "name": "Severe erythema",
            "percent": null
        },
        {
            "name": "face",
            "percent": null
        },
        {
            "name": "Severe stinging",
            "percent": null
        },
        {
            "name": "burning",
            "percent": null
        },
        {
            "name": "face",
            "percent": null
        },
        {
            "name": "Sunburn",
            "percent": null
        },
        {
            "name": "Severe erythema",
            "percent": null
        },
        {
            "name": "trunk",
            "percent": null
        },
        {
            "name": "Severe scaling",
            "percent": null
        },
        {
            "name": "face",
            "percent": null
        },
        {
            "name": "Severe dryness",
            "percent": null
        },
        {
            "name": "face",
            "percent": null
        },
        {
            "name": "Severe scaling",
            "percent": null
        },
        {
            "name": "trunk",
            "percent": null
        },
        {
            "name": "Application site pruritus",
            "percent": null
        },
        {
            "name": "Severe dryness",
            "percent": null
        },
        {
            "name": "trunk",
            "percent": null
        },
        {
            "name": "Severe scaling",
            "percent": null
        },
        {
            "name": "trunk",
            "percent": null
        }
    ]
}